Skip to main content
OpenTrials

Clinical trial condition

Myasthenia Gravis

Explore clinical trials studying Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

259 public trials 95 recruiting studies
Refine in advanced search Browse all conditions

Myasthenia Gravis trial results

Completed

An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

NCT03669588

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Investigator Site 29 Phoenix, Arizona, United States
  • Investigator Site 66 Carlsbad, California, United States
  • Investigator Site 5 Los Angeles, California, United States
  • Investigator Site 49 Los Angeles, California, United States
View all 66 locations
View Trial Details
Completed

Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis

NCT03052751

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • Mg0002 712 Los Angeles, California, United States
  • Mg0002 701 Orange, California, United States
  • Mg0002 713 Miami, Florida, United States
  • Mg0002 708 Tampa, Florida, United States
View all 20 locations
View Trial Details
Completed

Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis

NCT02100969

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • Phoenix Neurological Associates Phoenix, Arizona, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • University at Buffalo Buffalo, New York, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Completed

OVEMP in Myasthenia

NCT03049956

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • University Hospital Zurich, Ophthalmology/Neurology Department Zurich, Switzerland
View Trial Details
Completed

Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis

NCT02565576

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Québec, Quebec, Canada
  • Novartis Investigative Site Aarhus, Denmark
  • Novartis Investigative Site Copenhagen, Denmark
View all 15 locations
View Trial Details

Related conditions